Koenig, A., Reinecke, J., Halfen, J., Lang, K., Koenig, U., Tostmann, R., Kirchhof, N., Asendorf, T., Hörsch, D., Kröcher, A., Quante, M., Ellenrieder, V., Schulte, N., Wirth, T. C., Weich, A., Apostolidis, L., Rinke, A., Pavel, M., Krug, S., Seufferlein, T. (2025). Second interim analysis of CABONEN: An international, multicenter phase II trial investigating cabozantinib in patients with advanced, low proliferative NEN G3.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e16351